Insmed Incorporated (LON:0JAV)
London
· Delayed Price · Currency is GBP · Price in USD 81.39
-2.44 (-2.91%)
At close: Feb 21, 2025
Insmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 363.71 | 305.21 | 245.36 | 188.46 | 164.41 | Upgrade
|
| Revenue Growth (YoY) | 19.17% | 24.39% | 30.19% | 14.63% | 20.48% | Upgrade
|
| Cost of Revenue | 85.74 | 65.57 | 55.13 | 44.15 | 39.87 | Upgrade
|
| Gross Profit | 277.97 | 239.64 | 190.23 | 144.31 | 124.54 | Upgrade
|
| Selling, General & Admin | 461.12 | 344.5 | 265.78 | 233.67 | 203.61 | Upgrade
|
| Research & Development | 598.37 | 571.01 | 397.52 | 272.74 | 181.16 | Upgrade
|
| Operating Expenses | 1,065 | 920.56 | 668.36 | 511.47 | 389.77 | Upgrade
|
| Operating Income | -786.57 | -680.93 | -478.12 | -367.16 | -265.23 | Upgrade
|
| Interest Expense | -85.15 | -81.37 | -27.97 | -40.47 | -29.56 | Upgrade
|
| Interest & Investment Income | 53.31 | 42.13 | 11.08 | 0.17 | 1.7 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.03 | 1.86 | -5.94 | -3.33 | 0.41 | Upgrade
|
| EBT Excluding Unusual Items | -818.38 | -718.32 | -500.95 | -410.79 | -292.69 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -0.6 | - | Upgrade
|
| Other Unusual Items | -91.68 | -28.7 | 20.8 | -25.02 | - | Upgrade
|
| Pretax Income | -910.07 | -747.01 | -480.15 | -436.41 | -292.69 | Upgrade
|
| Income Tax Expense | 3.71 | 2.56 | 1.38 | -1.76 | 1.4 | Upgrade
|
| Net Income | -913.77 | -749.57 | -481.53 | -434.65 | -294.09 | Upgrade
|
| Net Income to Common | -913.77 | -749.57 | -481.53 | -434.65 | -294.09 | Upgrade
|
| Shares Outstanding (Basic) | 164 | 140 | 123 | 112 | 98 | Upgrade
|
| Shares Outstanding (Diluted) | 164 | 140 | 123 | 112 | 98 | Upgrade
|
| Shares Change (YoY) | 16.81% | 14.14% | 9.74% | 14.86% | 15.43% | Upgrade
|
| EPS (Basic) | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 | Upgrade
|
| EPS (Diluted) | -5.57 | -5.34 | -3.91 | -3.88 | -3.01 | Upgrade
|
| Free Cash Flow | -705.81 | -549.54 | -410.32 | -370.59 | -225.59 | Upgrade
|
| Free Cash Flow Per Share | -4.30 | -3.91 | -3.33 | -3.31 | -2.31 | Upgrade
|
| Gross Margin | 76.43% | 78.52% | 77.53% | 76.57% | 75.75% | Upgrade
|
| Operating Margin | -216.26% | -223.10% | -194.87% | -194.82% | -161.32% | Upgrade
|
| Profit Margin | -251.24% | -245.59% | -196.26% | -230.63% | -178.87% | Upgrade
|
| Free Cash Flow Margin | -194.06% | -180.05% | -167.23% | -196.64% | -137.21% | Upgrade
|
| EBITDA | -777.7 | -672.49 | -465.83 | -351.9 | -250 | Upgrade
|
| EBITDA Margin | -213.82% | -220.34% | -189.86% | -186.72% | -152.06% | Upgrade
|
| D&A For EBITDA | 8.88 | 8.44 | 12.29 | 15.26 | 15.23 | Upgrade
|
| EBIT | -786.57 | -680.93 | -478.12 | -367.16 | -265.23 | Upgrade
|
| EBIT Margin | -216.26% | -223.10% | -194.87% | -194.82% | -161.32% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.